Spontaneous Bilateral Femoral Fractures After High-Dose Zoledronic Acid.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26558671.
- Also identified by DOI 10.3928/01477447-20151020-16.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors report a case of spontaneous bilateral diaphyseal femoral fractures believed to be caused by oversuppression of bone remodeling as a result of long-term, high-dose treatment with bisphosphonate. The patient reported pain in both thighs before the fractures. Typical pathologic changes appeared on both femoral radiograph and bone scan before the fractures. Several hours after admission to the emergency department of the authors' institution, the patient underwent closed reduction and internal fixation with intramedullary nails for the bilateral femoral diaphyseal fractures. Treatment with zoledronic acid was immediately discontinued. In recent years, low-energy femoral diaphyseal fractures in patients undergoing long-term bisphosphonate treatment have been reported. It is believed that the prolonged treatment causes long-term suppression of bone remodeling and accumulation of microdamage. It is important to observe patients who are undergoing bisphosphonate treatment carefully. In this case study, the authors report the patient's unique medical history.
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Femoral Fractures
- Fractures, Spontaneous
- Imidazoles
Anatomy
- femur